tradingkey.logo
tradingkey.logo
Search

Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer

ReutersSep 24, 2025 6:44 AM
facebooktwitterlinkedin
View all comments0

- Burning Rock Biotech Ltd BNR.O:

  • BURNING ROCK'S ONCOGUIDE™ ONCOSCREEN™ PLUS CDX SYSTEM NOW APPROVED IN JAPAN AS A COMPANION DIAGNOSTIC FOR CAPIVASERTIB IN BREAST CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI